Advanced search
Start date
Betweenand

The effect of agomelatine in human platelets aggregation and adhesion

Grant number: 19/19488-0
Support type:Scholarships in Brazil - Master
Effective date (Start): June 01, 2020
Effective date (End): May 31, 2021
Field of knowledge:Biological Sciences - Pharmacology - General Pharmacology
Principal researcher:Gabriel Forato Anhê
Grantee:Julia Modesto Vicente
Home Institution: Faculdade de Ciências Médicas (FCM). Universidade Estadual de Campinas (UNICAMP). Campinas , SP, Brazil
Associated research grant:13/07607-8 - OCRC - Obesity and Comorbidities Research Center, AP.CEPID

Abstract

Several studies linked depression as an independent risk factor for the onset of cardiovascular disease. One reason for this correlation is the exacerbation of platelet activity described in patients diagnosed with Major Depressive Disorder (MDD). Among the therapeutic possibilities for depressed patients, selective serotonin reuptake inhibitors (SSRIs) demonstrate anti-aggregating ability. However, this class of drugs leads to a series of side effects that hinder their therapeutic use. Agomelatine, a drug with melatoninergic properties, is an option for treating DDM. Its differential is the agonist property of MT1 and MT2 receptors in parallel to the blockade of 5-HT2C serotonergic receptors. Although there are reports that platelet aggregation is inhibited by melatonin and potentiated by serotonin, it has not been established whether Agomelatine is capable of interfering with human platelet functional parameters. Thus, this study aims to analyze whether Agomelatine has the ability to inhibit platelet activity. We want to clarify whether these possible effects are due to either activation of MT1 / 2 receptors or blocking 5-HT2C receptors. Venous blood samples from 30 healthy 18- to 60-year-old male volunteers will be used to obtain platelet-rich plasma (PRP) and washed platelets for the execution of agonist-induced platelet aggregation assays (collagen, thrombin, ADP with or without Serotonin), platelet adhesion, quantification of Reactive Oxygen Species (ROS), change in conformation of integrin GPIIb / IIIa (±IIb²ƒ) by flow cytometry and intracellular calcium concentration ([Ca 2+]). (AU)

News published in Agência FAPESP Newsletter about the scholarship:
Articles published in other media outlets (0 total):
More itemsLess items
VEICULO: TITULO (DATA)
VEICULO: TITULO (DATA)